Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 22, 2000

View Archived Issues

Blair Backs UK Biotechnology, Urges 'More Rational' Dialogue

Ethics Group Favors Research On Stem Cell Research In EU

Healthy French Baby Results From Screening Of Embryos

Galapagos, Incyte Team For Target Discovery, Validation

IDM Raises EUR48.9M To Push Trials And Add New Programs

Mirieux Gains More Control As Transgene Ousts Gilly

European Commission Plans EUR100M Outlay For Genomics

Another European Committee Plans Biotechnology Focus

Other News To Note

University Spin-off Meltec Raises DM38M In Seed Financing Round

Epigenomics To Use Money From Funding For R&D, Infrastructure

Onyvax raises #10.5M To Boost Clinical Trials For Its Vaccines

VRI Seeks A$7.5M Via IPO For Diagnostic Technologies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.